Sulphonylurea Antidiabetic Drugs
- 1 January 1989
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 37 (1), 58-72
- https://doi.org/10.2165/00003495-198937010-00004
Abstract
Apart from the amelioration of symptoms, a major aim of the treatment of non-insulin-dependent diabetes mellitus (NIDDM, type 2 diabetes) should be the prevention of cardiovascular complications....Keywords
This publication has 87 references indexed in Scilit:
- Gliclazide Therapy Is Associated with Potentiation of Postbinding Insulin Action in Obese, Non-insulin-dependent Diabetic SubjectsDiabetes, 1985
- GliclazideDrugs, 1984
- Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acidsJournal of Medicinal Chemistry, 1984
- The Bedford Survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabeticsDiabetologia, 1982
- Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabeticsDiabetologia, 1981
- THE EFFECTS OF GLIBENCLAMIDE AND INSULIN ON PLASMA HIGH-DENSITY LIPOPROTEIN IN DIABETICS1981
- CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall StudyThe Lancet, 1980
- Diet-Induced Improvement of Abnormalities in Insulin and Glucagon Secretion and in Insulin Receptor Binding in Diabetes Mellitus*Journal of Clinical Endocrinology & Metabolism, 1979
- Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitusBMJ, 1978
- Appraisal of the Extrapancreatic Actions of SulfonylureasArchives of Internal Medicine, 1969